Iridex (IRIX) EBITDA Margin (2010 - 2026)

Iridex's EBITDA Margin history runs 17 years deep, the most recent figure standing at 2.75% for Q2 2026.

• On a quarterly basis, EBITDA Margin fell 102.0% year-over-year to 2.75% in Q2 2026; TTM through Apr 2026 was 5.12%, a 557.0% increase from a year earlier, with the FY2026 full-year figure at 4.88%, up 1218.0% from the prior year.
• EBITDA Margin retreated to 2.75% in Q2 2026 per IRIX's latest filing, from 0.1% in the prior quarter.
• Across five years, EBITDA Margin topped out at 0.1% in Q1 2026 and bottomed at 28.0% in Q1 2024.
• The 5-year median for EBITDA Margin is 12.36% (2022), against an average of 12.61%.
• Across the five-year window, EBITDA Margin slumped 1545 bps in 2023 and soared 2628 bps in 2025, its largest moves.
• Year by year, EBITDA Margin stood at 9.28% in 2022, then plunged by 167 bps to 24.73% in 2023, then soared by 84 bps to 3.95% in 2024, then tumbled by 186 bps to 11.3% in 2025, then jumped by 76 bps to 2.75% in 2026.
• Per Business Quant, the three latest IRIX EBITDA Margin figures stand at 2.75% (Q2 2026), 0.1% (Q1 2026), and 11.3% (Q3 2025).